Navigation Links
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/17/2011

nza Vaccines - Introduction 7

2.1 Disease Overview 7

2.2 Epidemiology 8

2.3 Etiology and Pathophysiology 8

2.3.1 Types of Influenza Virus 8

2.3.2 Source of Influenza Virus 9

2.3.3 Drifting and Shifting of Influenza Virus 9

2.4 Signs and Symptoms 11

2.5 Diagnosis 11

2.6 Treatment and Management Options 13

2.7 GlobalData Pipeline Report Guidance 14

3 Influenza Vaccines: Market Characterization 15

3.1 Influenza Vaccines Market Size (2005-2010) – Global 15

3.2 Influenza Vaccines Market Forecast (2011-2018) – Global 16

3.3 Influenza Vaccines Market Size (2005-2010) – The US 17

3.4 Influenza Vaccines Market Forecast (2011-2018) – The US 18

3.5 Influenza Vaccines Market Size (2005-2010) – France 19

3.6 Influenza Vaccines Market Forecast (2011-2018) – France 20

3.7 Influenza Vaccines Market Size (2005-2010) – Germany 21

3.8 Influenza Vaccines Market Forecast (2011-2018) – Germany 22

3.9 Influenza Vaccines Market Size (2005-2010) – Italy 23

3.10 Influenza Vaccines Market Forecast (2011-2018) – Italy 24

3.11 Influenza Vaccines Market Size (2005-2010) – Spain 25

3.12 Influenza Vaccines Market Forecast (2011-2018) – Spain 26

3.13 Influenza Vaccines Market Size (2005-2010) – The UK 27

3.14 Influenza Vaccines Market Forecast (2011-2018) – The UK 28

3.15 Influenza Vaccines Market Size (2005-2010) – Japan 29

3.16 Influenza Vaccines Market Forecast (2011-2018) – Japan 30

3.17 Drivers and Barriers for the Influenza Vaccines Market 31

3.17.1 Drivers for the Influenza Vaccines Market 31

3.17.2 Barriers for the Influenza Vaccines Market 32

3.18 Opportunity and Unmet Need Analysis 33

3.19 Key Takeaway 34

4 Influenza Vaccines: Competitive Assessment 35

4.1 Over
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
4. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
5. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
6. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
7. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
8. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
10. A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks
11. Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... A non-invasive blood,monitoring device that removes the need ... 2008 Kerrin Rennie Award for Excellence in Medical ... 24 September at the,Medical Technology Association of Australia ... CO-Oximeter from Masimo Corporation continuously,and non-invasively measures blood ...
... -, MONTVALE, N.J., Sept. 26 Memory,Pharmaceuticals Corp. ... completed,its Phase 1 multiple ascending dose study of R4996/MEM ... the fourth and final study,in the Company,s Phase 1 ... alpha-7 receptor being developed in collaboration with Roche.,Memory Pharmaceuticals ...
... a first, researchers at the University of Iowa and the ... cystic fibrosis (CF) that appears to closely mimic the disease ... the CF piglets and human newborns with CF suggest that ... and may also speed discovery of new treatments. The study ...
Cached Biology Technology:No Blood Needed Thanks to Innovative Medical Technology 2Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908 2Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908 3Researchers develop new model for cystic fibrosis 2
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... method for delivering molecules into single, targeted cells ... technique could find applications in drug delivery, cell ... a technique used to deliver molecules into ... that are caused by exposing them to electric ... cell transfection. (Cell transfection is the introduction of ...
(Date:5/21/2013)... University of Illinois at Chicago College of Medicine will study ... -- its main energy source -- and how changes in ... new $2 million, 4-year grant from the National Heart, Lung ... it uses fuel for energy. These changes may play a ... different in men and women, says E. Douglas Lewandowski, director ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Do men's and women's hearts burn fuel differently? 2
... raged over whether organic compounds and tiny globules of ... 84001 were processed by living creatures from the Red ... scrutiny ever since. Scientists at the Carnegie Institution's Geophysical ... how material associated with carbonate globules was created using ...
... more than 100 people have been infected with the H5N1 ... the fact that the virus does not spread easily from ... biomedical puzzle. , Now, a study of cells in the ... cells of the system that makes it difficult for the ...
... North America, two types of invasive vines are growing ... populations and bird habitats. , The vines are pale ... to stem the growth of and their steady conquest ... Canada, Cornell University is teaming up with the U.S. ...
Cached Biology News:Relic of life in that Martian meteorite? A fresh look 2Cell barrier shows why bird flu not so easily spread among humans 2Cell barrier shows why bird flu not so easily spread among humans 3CU, USDA team to curb two invasive, poisonous vines 2CU, USDA team to curb two invasive, poisonous vines 3
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
...
Biology Products: